These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

565 related items for PubMed ID: 6153859

  • 1. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK, Williams GH.
    Adv Intern Med; 1980; 25():327-61. PubMed ID: 6153859
    [No Abstract] [Full Text] [Related]

  • 2. [Renovascular hypertension. Concepts and reality].
    Ménard J, Corvol P, Plouin PF, Lagneau P.
    Arch Mal Coeur Vaiss; 1979 Nov; 72 Spec no():5-8. PubMed ID: 43713
    [No Abstract] [Full Text] [Related]

  • 3. Saralasin testing for renin-dependent hypertension.
    Weber MA.
    Arch Intern Med; 1979 Jan; 139(1):93-5. PubMed ID: 760691
    [No Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of renovascular hypertension and therapeutic decisions.
    Vaughan ED, Case DB, Pickering TG, Sosa RE, Sos TA, Laragh JH.
    Urol Clin North Am; 1984 Aug; 11(3):393-407. PubMed ID: 6205495
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacologic functional examination in arterial hypertension].
    Stumpe KO, Kolloch R, Overlack A.
    Internist (Berl); 1977 Nov; 18(11):594-600. PubMed ID: 23361
    [No Abstract] [Full Text] [Related]

  • 6. Use of angiotensin antagonists in experimental and human renovascular hypertension.
    Maxwell MH.
    Adv Nephrol Necker Hosp; 1979 Nov; 8():297-319. PubMed ID: 115245
    [No Abstract] [Full Text] [Related]

  • 7. [Physiopathology of arterial hypertension. II--The renin-angiotensin-aldosterone system].
    Francischetti EA, Oigman W, Fagundes VG, Sanjuliani AF, Netto FR, Brandão AP.
    Arq Bras Cardiol; 1985 Jan; 44(1):57-71. PubMed ID: 3904677
    [No Abstract] [Full Text] [Related]

  • 8. Is the peripheral sympatho-adrenal nervous system necessary for renal hypertension?
    Douglas JR, Johnson EM, Heist JF, Marshall GR, Needleman P.
    J Pharmacol Exp Ther; 1976 Jan; 196(1):35-43. PubMed ID: 1246014
    [Abstract] [Full Text] [Related]

  • 9. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET, Stinson J, Ramirez G.
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [Abstract] [Full Text] [Related]

  • 10. Cardiac consequences of aldosterone excess in human hypertension.
    Rossi GP.
    Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
    [No Abstract] [Full Text] [Related]

  • 11. Plasma aldosterone during haemodialysis in patients with terminal renal failure.
    Vetter W, Záruba K, Armbuster H, Strebel U, Beckerhoff R, Siegenthaler W.
    Proc Eur Dial Transplant Assoc; 1973 Jan; 10(0):332-41. PubMed ID: 4370265
    [No Abstract] [Full Text] [Related]

  • 12. [Experimental bases of the pathophysiology of the renin-angiotensin system].
    Gross F.
    Verh Dtsch Ges Inn Med; 1968 Jan; 74():27-41. PubMed ID: 4306314
    [No Abstract] [Full Text] [Related]

  • 13. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK, Williams GH.
    Kidney Int Suppl; 1979 Mar; (9):S29-35. PubMed ID: 384070
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin antagonists as diagnostic and pharmacologic tools.
    Pettinger WA, Mitchell HC.
    Prog Biochem Pharmacol; 1976 Mar; 12():203-13. PubMed ID: 798203
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.